(Q33820302)

English

Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux® and particle therapy].

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Combined treatment of adenoid cystic carcinoma with cetuximab and IMRT plus C12 heavy ion boost: ACCEPT [ACC, Erbitux® and particle therapy]. (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

based on heuristic

inferred from title

adenoid cystic carcinoma

1 reference

based on heuristic

inferred from title

4

object named as

Jürgen Debus

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Alexandra D Jensen

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Anna Nikoghosyan

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Axel Hinke

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Marc W Münter

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

15 February 2011

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

70

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-11-70

0 references

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042975

4 July 2018

Outcomes of postoperative concurrent chemoradiotherapy for locally advanced major salivary gland carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042975

4 July 2018

Systemic therapy in the palliative management of advanced salivary gland cancers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042975

4 July 2018

Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042975

4 July 2018

Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the treatment of incompletely and completely resected adenoid cystic carcinomas of the head and neck: initial clinical results and toxicity of treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042975

4 July 2018

Chemoradiotherapy for adenoid cystic carcinoma: preliminary results of an organ sparing approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042975

4 July 2018

Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042975

4 July 2018

Adenoid cystic carcinoma of the major salivary glands treated with surgery and radiation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042975

4 July 2018

Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042975

4 July 2018

The role of radiotherapy in the treatment of malignant salivary gland tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042975

4 July 2018

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042975

4 July 2018

Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042975

4 July 2018

Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042975

4 July 2018

Optimal two-stage designs for phase II clinical trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042975

4 July 2018

Local-regional recurrence after surgery without postoperative irradiation for carcinomas of the major salivary glands: implications for adjuvant therapy

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-70

21 January 2018

Chemoreirradiation for recurrent salivary gland malignancies

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-70

21 January 2018

Concomitant inhibition of epidermal growth factor and vascular endothelial growth factor receptor tyrosine kinases reduces growth and metastasis of human salivary adenoid cystic carcinoma in an orthotopic nude mouse model.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-70

21 January 2018

Imatinib mesylate in patients with adenoid cystic cancers of the salivary glands expressing c-kit: a Princess Margaret Hospital phase II consortium study

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-70

21 January 2018

Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-11-70

21 January 2018

Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam?

1 reference

https://pubmed.ncbi.nlm.nih.gov/21320355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Concomitant chemoradiotherapy followed by adjuvant chemotherapy in parotid gland undifferentiated carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/21320355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21320355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of salivary gland neoplasms with fast neutron radiotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21320355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/21320355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dose escalation study of carbon ion radiotherapy for locally advanced head-and-neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21320355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salivary neoplasms: overview of a 35-year experience with 2,807 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21320355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin

1 reference

https://pubmed.ncbi.nlm.nih.gov/21320355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin-based chemotherapy for neoplasms arising from salivary glands and contiguous structures in the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/21320355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21320355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/21320355

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2407-11-70

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33820302&oldid=1968183201"